Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: A randomised controlled trial

Lancet

Volumn 354, Issue 9184, 1999, Pages 1066-1071

  Mercier, Jean Christophe ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT EXTRACT; NITRIC OXIDE; OXYGEN;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; HYPOXEMIA; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; LUNG ALVEOLUS OXYGEN TENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; TREATMENT OUTCOME;

EID: 0033604020     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)03309-7     Document Type: Note

References (27)

1. Kinsella J.P., Abman S.H. Recent developments in the pathophysiology and treatment of PPHN. J Pediatr. 126:1995;853-864.
2. Ignarro L.J., Buga G.M., Wood K.S., Bryns R.E., Chauduri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci. 84:1987;9265-9269.
3. Palmer R.M.J., Ferrige A., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;523-526.
4. Pepke-Zaba J., Higenbottam T.W., Dinh-Xuan A.T., Stone D., Wallwork J. Inhaled nitric oxide as a cause of selective pulmonary vasodilation in pulmonary hypertension. Lancet. 338:1991;1173-1174.
5. Roberts J.D., Polaner D.M., Lang P., Zapol W.M. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 340:1992;818-819.
6. Kinsella J.P., Neish S.R., Shaffer E., Abman S.H. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 340:1992;819-820.
7. Day R.W., Lynch J.M., White K.S., Ward R.M. Acute response to inhaled nitric oxide in newborns with respiratory failure and pulmonary hypertension. Pediatrics. 98:1996;698-705.
8. Goldman A.P., Tasker R.C., Haworth S.G., Sigston P.E., Macrae D.J. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics. 98:1996;706-713.
9. Mercier, J.C., Lacaze, T., Storme, L., Rozé, J.C., Dinh-Xuan, A.T., Dehan, M., and the French paediatric study group of inhaled NO. Disease-related response to inhaled nitric oxide in newborns with severely hypoxaemic respiratory failure. Eur J Pediatr 1998; 157: 747-52.
10. Steinhorn R.H., Cox P.N., Fineman J.R.et al. Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr. 130:1997;417-422.
11. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 336:1997;597-604.
12. Roberts J.D., Fineman J.R., Morin F.C.et al. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med. 336:1997;605-610.
13. Kinsella J.P., Truog W.E., Walsh W.F.et al. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr. 131:1997;55-62.
14. Wessel D.L., Adatia I., van Marter L.J.et al. Improved oxygenation in a randomized clinical trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics. 100:1997;e7.
15. Davidson D., Barefield E.S., Kattwinkel J.et al. Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics. 101:1998;325-334.
16. van Meurs, K.P., Rhine, W.D., Asselin, J.M., Durand, D.J., and the Preemie NO Collaborative Group. Response of premature infants with severe respiratory failure to inhaled nitric oxide. Pediatr Pulmonol 1997; 24: 319-23.
17. Finer N.N., Etches P.C., Kamstra B., Tierney A.J., Peliowski A., Ryan C.A. Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response. J Pediatr. 124:1994;302-308.
18. Jobe A.H. Pulmonary surfactant therapy. N Engl J Med. 328:1993;861-868.
19. Walther F.J., Benders M.J., Leighton J.O. Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics. 90:1992;899-904.
20. Finer, N.N., Barrington, K.J. Nitric oxide in respiratory failure in full-term and nearly full-term newborn infants failure. In: Cochrane Library [CDROM and online]: review no 000399. Cochrane Collaboration; issue 1. Oxford: Update Software, 1999.
21. Barrington, K.J., Finer, N.N. Inhaled nitric oxide in preterm newborn infants with respiratory failure. In: Cochrane Library [CDROM and online]: review no 000509. Cochrane Collaboration; issue 1. Oxford: Update Software, 1999.
22. Skimming J.W., Bender K.A., Hutchinson A.A., Drummond W.H. Nitric oxide inhalation in infants with respiratory distress syndrome. J Pediatr. 130:1997;225-230.
23. Subhedar N.V., Ryan S.W., Shaw N.J. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child. 77:1997;185-190.
24. Subhedar N.V., Shaw N.J. Changes in oxygenation and pulmonary hemodynamics in preterm infants treated with inhaled nitric oxide. Arch Dis Child. 77:1997;191-197.
25. Cheung P.Y., Peliowski A., Robertson C.M.T. The outcome of very low birth weight neonates (≤1500 g) rescued by inhaled nitric oxide: neurodevelopment in early childhood. J Pediatr. 133:1998;735-739.
26. Kinsella J.P., Parker T.A., Galan H., Sheridan B.C., Halbower A.C., Abman S.H. Effects of inhaled nitric oxide on pulmonary edema and lung neutrophil accumulation in severe experimental hyaline membrane disease. Pediatr Res. 41:1997;457-463.
27. Christou H., Magnani B., Morse D.S.et al. Inhaled nitric oxide does not affect adenosine 5'-diphosphate-dependent platelet activation in infants with persistent pulmonary hypertension of the newborn. Pediatrics. 102:1998;1390-1393.